IFS is believed to be a useful treatment for PTSD. A new study provides the first research-based evidence of its efficacy.
Back in 2024, Renesas first released the RA0E1, an ultra-low-power Cortex-M23 MCU designed for cost-sensitive applications, followed by the RA0E2, with ...
A team of University of Michigan investigators reported that their multimodal, chronic disease self-management support program for people living with glaucoma, SEE, was linked to an approximate 20% ...
A peer navigator intervention following a nonfatal opioid overdose in the emergency department does not significantly reduce ...
The cobot feeder includes a storage and retrieval assembly with a UR force- and power-limited robot pedestal, enclosed steel ...
The trials are evaluating DURAVYU (vorolanib intravitreal insert) for the treatment of diabetic macular edema (DME).
Texas Instruments is developing GaN power devices to enable more compact and efficient motor joints for humanoid robots.
Active Phase 3 programs for DURAVYU in wet AMD and DME, the two largest multi-billion-dollar retinal disease markets - ...
Opinion
Mediaite on MSNOpinion
CNN’s Fareed Zakaria Goes Off on ‘Blue Cities’ Like LA and New York for Being ‘Out of Control’
CNN anchor Fareed Zakaria opened his program on Sunday by skewering "blue cities" like Los Angeles and New York for being dysfunctional embarrassments The post CNN’s Fareed Zakaria Goes Off on ‘Blue ...
Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...
Both pivotal Phase 3 trials for DURAVYU in wet AMD on track for data readout beginning in mid-2026 - - Patients dosed in both COMO and CAPRI Phase 3 clinical trials for DURAVYU in DME - - Michael ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results